Form Type: 4

SEC EDGAR Link
Accession Number:0001725160-21-000175
Date:2021-08-02
Issuer: ZENTALIS PHARMACEUTICALS, INC. (ZNTL)
Original Submission Date:

Reporting Person:

BUNKER KEVIN D.
C/O ZENTALIS PHARMACEUTICALS, INC.
530 SEVENTH AVENUE, SUITE 2201 NEW YORK, NY 10018

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-08-02 S 3,139 d $49.92 22,121 indirect f3
COMMON STOCK 2021-08-02 S 3,728 d $51.35 18,393 indirect f3
COMMON STOCK 2021-08-02 S 1,246 d $52.41 17,147 indirect f3
COMMON STOCK 2021-08-02 S 307 d $53.32 16,840 indirect f3
COMMON STOCK 2021-08-02 0 $0.00 994,841 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sale reported in the form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on september 21, 2020.
f2 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $49.57 to $50.27. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f3 represents shares nominally held by sundog ranch, inc. on behalf of the bunker family protection trust, the sole shareholder of sundog ranch, inc. the reporting person and his wife are the primary beneficiaries of the bunker family protection trust and the reporting person and his wife are also directors of sundog ranch, inc. the reporting person disclaims beneficial ownership of the securities held by sundog ranch, inc. except to the extent of his pecuniary interest therein, if any.
f4 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $50.92 to $51.90. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f5 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $51.92 to $52.86. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f6 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $53.02 to $53.49. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
WhaleWisdom Logo

Elevate your investments